DrugPatentWatch Database Preview

Norway Supplementary Protection Certificates

« Back to Dashboard

Supplementary Protection Certificates

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Country	Patent Number	Supplementary Protection Certificate	SPC Country	SPC Description	SPC Expiration
European Patent Office	2957286	2018041	Norway	PRODUCT NAME: PATIROMERSORBITEKSKALSIUM; REG. NO/DATE: EU/1/17/1179 20170809
European Patent Office	2525812	2017034	Norway	PRODUCT NAME: IDARUCIZUMAB; REG. NO/DATE: 20151124
European Patent Office	2182988	2015006	Norway	PRODUCT NAME: VIZAMYL; REG. NO/DATE: EU/1/14/941 20140822
European Patent Office	2441753	2017026	Norway	PRODUCT NAME: ALEKTINIB ELLER SALT ELLER SOLVAT; REG. NO/DATE: EU/1/16/1169 20170307
European Patent Office	2459208	2017021	Norway	PRODUCT NAME: ETELKALSETID, ELLER ET SALT DERAV, INKLUDERT ETELKALSETIDHYDROKLORID; NAT. REG. NO/DATE: EU/1/16/1142 20161122; FIRST REG. NO/DATE: EU/1/16/1142/001-012 20161115
European Patent Office	2203462	2014029	Norway	PRODUCT NAME: SOFOSBUVIR. (S)-ISOPROPYL 2-; NAT. REG. NO/DATE: EU/1/13/894 20140116; FIRST REG. NO/DATE: (001-002) 20140117
European Patent Office	2368890	2015012	Norway	PRODUCT NAME: OMBITASVIR, ELLER ET; REG. NO/DATE: EU/1/14/982 20150120